ACA
NEUTRALM&AArcosa, Inc.
Price
$145.28
-0.14%This is the 2026-08-28 snapshot — the signals and analysis for ACA as of this single trading day.
View full ACA research hub →Score9.5Priority
Signals6/8 DNA0/13 Act · 0/4 Risk
SentimentNEUTRALScore: 7
Volume1.0xvs 20d avg
Analysis
Arcosa's (ACA) exceptionally tight price action and historically low 2.8% volatility are directly driven by CRH's pending $150-per-share all-cash acquisition offer. The stock's QUIET_STORM and PERFECT_STACK technical signals reflect classic merger arbitrage behavior, where institutional buyers anchor the price and absorb any fundamental weakness, such as the recent Q2 earnings miss. Furthermore, the current RISK_ON macro regime provides ultimate conviction in the deal's viability. With corporate credit spreads at a mere 0.79% and the VIX at 14.5, there is zero liquidity stress in the system to threaten the acquirer's financing.
Fired Signals
ALPHA MALEQUIET STORMSTEADY CLIMBGOLDEN CROSSMARKET LEADERPERFECT STACK
Key Takeaways
- Actionable Thesis: ACA is pinned near $145 due to CRH's $150 all-cash acquisition, offering a defined merger arbitrage spread [1.2.5].
- Key Risk: Regulatory or antitrust hurdles could delay or block the Q1 2027 acquisition close, breaking the current price floor.
- What to Watch: Monitor the $144.73 support level and any upcoming shareholder or regulatory approval announcements.
© 2026 Signal52 • For educational purposes only